Kriya Therapeutics
PrivateLast Round
Series D
9/10/2025
Total Funding Raised
$920.5M
Company Overview
Kriya Therapeutics is a biotechnology company focused on designing and developing gene therapies for diseases with specific biological underpinnings.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kriya Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Kriya Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 9/10/2025 | ||||
| Series C Extension | 7/26/2023 | ||||
| Series C | 5/16/2022 | ||||
| Series B | 7/14/2021 | ||||
| Series A | 5/12/2020 |
Key People
Founding team and executive leadership
Kriya Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Narya Capital | Series C, Series B, Series A, Series D |
| CAM Capital | Series C, Series B |
| Amplo | Series B, Series A |
| Patient Square Capital | Series C, Series C Extension, Series B, Series D |
| Hongkou Capital | Series B |
| Foresite Capital | Series C, Series B, Series A |
| Bluebird Ventures | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2026
Hiring business owner for Dot Compliance eQMS platform.
- Sep 10, 2025
$320M Series D round completed.
Kriya Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kriya Therapeutics's valuation, stock price, and market status.
